{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:08:08Z","timestamp":1791216488312,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Reactivation of chemotherapy-induced dormant cancer cells is the main cause of relapse and metastasis. The molecular mechanisms underlying remain to be elucidated. In this study, we introduced a cellular model that mimics the process of cisplatin responsiveness in NSCLC patients. We found that during the process of dormancy and reactivation induced by cisplatin, NSCLC cells underwent sequential EMT-MET with enrichment of cancer stem cells. The ATAC-seq combined with motif analysis revealed that OCT4-SOX2-TCF-NANOG motifs were associated with the enrichment of cancer stem cells induced by chemotherapy. Gene expression profiling suggested a dynamic regulatory mechanism during the process of enrichment of cancer stem cells, where Nanog showed upregulation in the dormant state and SOX2 showed upregulation in the reactivated state. Further, we showed that EphB1 and p-EphB1 showed dynamic expression in the process of cancer cell dormancy and reactivation, where the expression profiles of EphB1 and p-EphB1 showed negatively correlated. In the dormant EMT cells which showed disrupted cell-cell contacts, ligand-independent EphB1 promoted entry of lung cancer cells into dormancy through activating p-p38 and downregulating E-cadherin. On the contrary, in the state of MET, in which cell-cell adhesion was recovered, interactions of EphB1 and ligand EphrinB2 in trans promoted the stemness of cancer cells through upregulating Nanog and Sox2. In conclusion, lung cancer stem cells were enriched during the process of cellular response to chemotherapy. EphB1 cis- and trans- signalings function in the dormant and reactivated state of lung cancer cells respectively. It may provide a therapeutic strategy that target the evolution process of cancer cells induced by chemotherapy.<\/jats:p>","DOI":"10.1038\/s41419-022-05385-5","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T12:03:11Z","timestamp":1668859391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cell-cell contact-driven EphB1 cis- and trans- signalings regulate cancer stem cells enrichment after chemotherapy"],"prefix":"10.1038","volume":"13","author":[{"given":"Lujuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8712-8952","authenticated-orcid":false,"given":"Juanjuan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"key":"5385_CR1","doi-asserted-by":"publisher","first-page":"12845","DOI":"10.1073\/pnas.1109632108","volume":"108","author":"I Dey-Guha","year":"2011","unstructured":"Dey-Guha I, Wolfer A, Yeh AC, J GA, Darp R, Leon E, et al. Asymmetric cancer cell division regulated by AKT. Proc Natl Acad Sci USA. 2011;108:12845\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5385_CR2","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1158\/0008-5472.CAN-15-1370","volume":"75","author":"AC Yeh","year":"2015","unstructured":"Yeh AC, Ramaswamy S. Mechanisms of Cancer Cell Dormancy-Another Hallmark of Cancer? Cancer Res. 2015;75:5014\u201322.","journal-title":"Cancer Res"},{"key":"5385_CR3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nrc2256","volume":"7","author":"JA Aguirre-Ghiso","year":"2007","unstructured":"Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 2007;7:834\u201346.","journal-title":"Nat Rev Cancer"},{"key":"5385_CR4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3389\/fonc.2018.00505","volume":"8","author":"X Yang","year":"2018","unstructured":"Yang X, Liang X, Zheng M, Tang Y. Cellular Phenotype Plasticity in Cancer Dormancy and Metastasis. Front Oncol. 2018;8:505.","journal-title":"Front Oncol"},{"key":"5385_CR5","doi-asserted-by":"publisher","first-page":"7443","DOI":"10.1038\/sj.onc.1209091","volume":"24","author":"L Larue","year":"2005","unstructured":"Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3\u2019 kinase\/AKT pathways. Oncogene 2005;24:7443\u201354.","journal-title":"Oncogene"},{"key":"5385_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/bs.acr.2018.12.002","volume":"141","author":"S Talukdar","year":"2019","unstructured":"Talukdar S, Bhoopathi P, Emdad L, Das S, Sarkar D, Fisher PB. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting. Adv Cancer Res. 2019;141:43\u201384.","journal-title":"Adv Cancer Res"},{"key":"5385_CR7","doi-asserted-by":"crossref","unstructured":"Lisabeth EM, Falivelli G, Pasquale EB. Eph receptor signaling and ephrins. Cold Spring Harb Perspect Biol. 2013;5:a009159.","DOI":"10.1101\/cshperspect.a009159"},{"key":"5385_CR8","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature07423","volume":"455","author":"L Ding","year":"2008","unstructured":"Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008;455:1069\u201375.","journal-title":"Nature"},{"key":"5385_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0092-8674(01)00314-2","volume":"105","author":"SM Shamah","year":"2001","unstructured":"Shamah SM, Lin MZ, Goldberg JL, Estrach S, Sahin M, Hu L, et al. EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell 2001;105:233\u201344.","journal-title":"Cell"},{"key":"5385_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5732\/cjc.013.10108","volume":"33","author":"RX Li","year":"2014","unstructured":"Li RX, Chen ZH, Chen ZK. The role of EPH receptors in cancer-related epithelial-mesenchymal transition. Chin J Cancer. 2014;33:231\u201340.","journal-title":"Chin J Cancer"},{"key":"5385_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s10555-012-9352-1","volume":"31","author":"M Kandouz","year":"2012","unstructured":"Kandouz M. The Eph\/Ephrin family in cancer metastasis: communication at the service of invasion. Cancer Metastasis Rev. 2012;31:353\u201373.","journal-title":"Cancer Metastasis Rev"},{"key":"5385_CR12","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/ncb2298","volume":"13","author":"G Solanas","year":"2011","unstructured":"Solanas G, Cortina C, Sevillano M, Batlle E. Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling. Nat Cell Biol. 2011;13:1100\u20137.","journal-title":"Nat Cell Biol"},{"key":"5385_CR13","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1038\/onc.2013.238","volume":"33","author":"J Huang","year":"2014","unstructured":"Huang J, Xiao D, Li G, Ma J, Chen P, Yuan W, et al. EphA2 promotes epithelial-mesenchymal transition through the Wnt\/beta-catenin pathway in gastric cancer cells. Oncogene 2014;33:2737\u201347.","journal-title":"Oncogene"},{"key":"5385_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1167\/iovs.17-22941","volume":"59","author":"N Kaplan","year":"2018","unstructured":"Kaplan N, Ventrella R, Peng H, Pal-Ghosh S, Arvanitis C, Rappoport JZ, et al. EphA2\/Ephrin-A1 Mediate Corneal Epithelial Cell Compartmentalization via ADAM10 Regulation of EGFR Signaling. Invest Ophthalmol Vis Sci. 2018;59:393\u2013406.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5385_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-017-0384-z","volume":"17","author":"W Wei","year":"2017","unstructured":"Wei W, Wang H, Ji S. Paradoxes of the EphB1 receptor in malignant brain tumors. Cancer Cell Int. 2017;17:21.","journal-title":"Cancer Cell Int"},{"key":"5385_CR16","doi-asserted-by":"publisher","first-page":"8929","DOI":"10.18632\/oncotarget.3369","volume":"6","author":"S Bhatia","year":"2015","unstructured":"Bhatia S, Baig NA, Timofeeva O, Pasquale EB, Hirsch K, MacDonald TJ, et al. Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization. Oncotarget 2015;6:8929\u201346.","journal-title":"Oncotarget"},{"key":"5385_CR17","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.7150\/jca.44576","volume":"11","author":"L Wang","year":"2020","unstructured":"Wang L, Peng Q, Sai B, Zheng L, Xu J, Yin N, et al. Ligand-independent EphB1 signaling mediates TGF-beta-activated CDH2 and promotes lung cancer cell invasion and migration. J Cancer. 2020;11:4123\u201331.","journal-title":"J Cancer"},{"key":"5385_CR18","doi-asserted-by":"publisher","first-page":"6567","DOI":"10.1038\/s41388-019-0931-2","volume":"38","author":"LY Liang","year":"2019","unstructured":"Liang LY, Patel O, Janes PW, Murphy JM, Lucet IS. Eph receptor signalling: from catalytic to non-catalytic functions. Oncogene 2019;38:6567\u201384.","journal-title":"Oncogene"},{"key":"5385_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2005.01.020","volume":"121","author":"T Marquardt","year":"2005","unstructured":"Marquardt T, Shirasaki R, Ghosh S, Andrews SE, Carter N, Hunter T, et al. Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell 2005;121:127\u201339.","journal-title":"Cell"},{"key":"5385_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.semcdb.2011.10.025","volume":"23","author":"JP Himanen","year":"2012","unstructured":"Himanen JP. Ectodomain structures of Eph receptors. Semin Cell Dev Biol. 2012;23:35\u201342.","journal-title":"Semin Cell Dev Biol"},{"key":"5385_CR21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nsmb.1782","volume":"17","author":"E Seiradake","year":"2010","unstructured":"Seiradake E, Harlos K, Sutton G, Aricescu AR, Jones EY. An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly. Nat Struct Mol Biol. 2010;17:398\u2013402.","journal-title":"Nat Struct Mol Biol"},{"key":"5385_CR22","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1101\/gad.1630408","volume":"22","author":"D Arvanitis","year":"2008","unstructured":"Arvanitis D, Davy A. Eph\/ephrin signaling: networks. Genes Dev. 2008;22:416\u201329.","journal-title":"Genes Dev"},{"key":"5385_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.neures.2003.11.009","volume":"48","author":"Y Yin","year":"2004","unstructured":"Yin Y, Yamashita Y, Noda H, Okafuji T, Go MJ, Tanaka H. EphA receptor tyrosine kinases interact with co-expressed ephrin-A ligands in cis. Neurosci Res. 2004;48:285\u201396.","journal-title":"Neurosci Res"},{"key":"5385_CR24","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1101\/gad.1973910","volume":"24","author":"ME Pitulescu","year":"2010","unstructured":"Pitulescu ME, Adams RH. Eph\/ephrin molecules-a hub for signaling and endocytosis. Genes Dev. 2010;24:2480\u201392.","journal-title":"Genes Dev"},{"key":"5385_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ydbio.2018.01.012","volume":"447","author":"TK Niethamer","year":"2019","unstructured":"Niethamer TK, Bush JO. Getting direction(s): The Eph\/ephrin signaling system in cell positioning. Dev Biol. 2019;447:42\u201357.","journal-title":"Dev Biol"},{"key":"5385_CR26","doi-asserted-by":"publisher","first-page":"e98021","DOI":"10.1371\/journal.pone.0098021","volume":"9","author":"S Li","year":"2014","unstructured":"Li S, Kennedy M, Payne S, Kennedy K, Seewaldt VL, Pizzo SV, et al. Model of tumor dormancy\/recurrence after short-term chemotherapy. PLoS ONE. 2014;9:e98021.","journal-title":"PLoS ONE"},{"key":"5385_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.omtn.2021.07.019","volume":"26","author":"L Wang","year":"2021","unstructured":"Wang L, Peng Q, Yin N, Xie Y, Xu J, Chen A, et al. Chromatin accessibility regulates chemotherapy-induced dormancy and reactivation. Mol Ther Nucleic Acids. 2021;26:269\u201379.","journal-title":"Mol Ther Nucleic Acids"},{"key":"5385_CR28","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1111\/1759-7714.14147","volume":"12","author":"J Xu","year":"2021","unstructured":"Xu J, Wang L, Yin N, Chen A, Yi J, Tang J, et al. Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC. Thorac Cancer. 2021;12:2601\u201310.","journal-title":"Thorac Cancer"},{"key":"5385_CR29","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1093\/bioinformatics\/btu372","volume":"30","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Lin YH, Johnson TD, Rozek LS, Sartor MA. PePr: a peak-calling prioritization pipeline to identify consistent or differential peaks from replicated ChIP-Seq data. Bioinformatics 2014;30:2568\u201375.","journal-title":"Bioinformatics"},{"key":"5385_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-9-269","volume":"9","author":"AA Sharov","year":"2008","unstructured":"Sharov AA, Masui S, Sharova LV, Piao Y, Aiba K, Matoba R, et al. Identification of Pou5f1, Sox2, and Nanog downstream target genes with statistical confidence by applying a novel algorithm to time course microarray and genome-wide chromatin immunoprecipitation data. BMC Genom. 2008;9:269.","journal-title":"BMC Genom."},{"key":"5385_CR31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fonc.2018.00381","volume":"8","author":"K Weidenfeld","year":"2018","unstructured":"Weidenfeld K, Barkan D. EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes? Front Oncol. 2018;8:381.","journal-title":"Front Oncol"},{"key":"5385_CR32","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2013.10.029","volume":"155","author":"FG Giancotti","year":"2013","unstructured":"Giancotti FG. Mechanisms governing metastatic dormancy and reactivation. Cell 2013;155:750\u201364.","journal-title":"Cell"},{"key":"5385_CR33","doi-asserted-by":"crossref","unstructured":"Hamidi S, Nakaya Y, Nagai H, Alev C, Kasukawa T, Chhabra S, et al. Mesenchymal-epithelial transition regulates initiation of pluripotency exit before gastrulation. Development. 2020;147:dev184960.","DOI":"10.1242\/dev.184960"},{"key":"5385_CR34","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/stem.456","volume":"28","author":"T Chen","year":"2010","unstructured":"Chen T, Yuan D, Wei B, Jiang J, Kang J, Ling K, et al. E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation. Stem Cells. 2010;28:1315\u201325.","journal-title":"Stem Cells"},{"key":"5385_CR35","doi-asserted-by":"crossref","unstructured":"Vellingiri B, Iyer M, Devi Subramaniam M, Jayaramayya K, Siama Z, Giridharan B, et al. Understanding the Role of the Transcription Factor Sp1 in Ovarian Cancer: from Theory to Practice. Int J Mol Sci. 2020;21:1153.","DOI":"10.3390\/ijms21031153"},{"key":"5385_CR36","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1073\/pnas.1918167117","volume":"117","author":"TY Na","year":"2020","unstructured":"Na TY, Schecterson L, Mendonsa AM, Gumbiner BM. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc Natl Acad Sci USA. 2020;117:5931\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5385_CR37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s43018-020-0068-9","volume":"1","author":"HC Lo","year":"2020","unstructured":"Lo HC, Xu Z, Kum LS, Pingel B, Aguirre S, Kodali S, et al. Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasis. Nat Cancer. 2020;1:709\u201322.","journal-title":"Nat Cancer"},{"key":"5385_CR38","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1083\/jcb.201512010","volume":"214","author":"TN Gaitanos","year":"2016","unstructured":"Gaitanos TN, Koerner J, Klein R. Tiam-Rac signaling mediates trans-endocytosis of ephrin receptor EphB2 and is important for cell repulsion. J Cell Biol. 2016;214:735\u201352.","journal-title":"J Cell Biol"},{"key":"5385_CR39","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1126\/science.1948064","volume":"254","author":"BC Cunningham","year":"1991","unstructured":"Cunningham BC, Ultsch M, De Vos AM, Mulkerrin MG, Clauser KR, Wells JA. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 1991;254:821\u20135.","journal-title":"Science"},{"key":"5385_CR40","doi-asserted-by":"crossref","unstructured":"Martinez-Limon A, Joaquin M, Caballero M, Posas F, de Nadal E. The p38 Pathway: From Biology to Cancer Therapy. Int J Mol Sci. 2020;21:1913.","DOI":"10.3390\/ijms21061913"},{"key":"5385_CR41","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrc3793","volume":"14","author":"MS Sosa","year":"2014","unstructured":"Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14:611\u201322.","journal-title":"Nat Rev Cancer"},{"key":"5385_CR42","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.cell.2006.03.048","volume":"125","author":"IE Zohn","year":"2006","unstructured":"Zohn IE, Li Y, Skolnik EY, Anderson KV, Han J, Niswander L. p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation. Cell 2006;125:957\u201369.","journal-title":"Cell"},{"key":"5385_CR43","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/bioinformatics\/btn025","volume":"24","author":"R Li","year":"2008","unstructured":"Li R, Li Y, Kristiansen K, Wang J. SOAP: short oligonucleotide alignment program. Bioinformatics 2008;24:713\u20134.","journal-title":"Bioinformatics"},{"key":"5385_CR44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12:357\u201360.","journal-title":"Nat Methods"},{"key":"5385_CR45","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.csbj.2019.04.012","volume":"17","author":"IA Babarinde","year":"2019","unstructured":"Babarinde IA, Li Y, Hutchins AP. Computational Methods for Mapping, Assembly and Quantification for Coding and Non-coding Transcripts. Comput Struct Biotechnol J 2019;17:628\u201337.","journal-title":"Comput Struct Biotechnol J"},{"key":"5385_CR46","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"5385_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinforma. 2011;12:323.","journal-title":"BMC Bioinforma"},{"key":"5385_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"5385_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9:R137.","journal-title":"Genome Biol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05385-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05385-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05385-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T08:04:44Z","timestamp":1669017884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05385-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["5385"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05385-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"21 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All aspects of this study were approved by the ethical review committees of the second Xiangya Hospital, Central South University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"980"}}